At the 2013 Grand Challenges meeting, Jorge Kalil discussed how to develop a human vaccine directed against an antigen implicated in triggering an autoimmune disease: the case of Streptococcus pyogenes.
From the 2013 meeting in Rio de Janeiro, Brazil
Oct 28, 2013